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Background: Kaposi’s sarcoma (KS) is an angioproliferative malignancy caused by infection with human herpes virus 
-8 (HHV-8). The tumour has four subtypes including Classic KS, African- endemic, Iatrogenic and Acquired 
immunodeficiency syndrome (AIDS)-related KS. AIDS- related KS is the most common malignancy in patients with 
human immunodeficiency virus (HIV) infection and has variable clinical presentation with diverse distribution of 
lesions.  
Objective: To assess the pattern of distribution of KS lesions in patients with AIDS-related KS at Kenyatta National 
Hospital. 
Methods: We carried out a descriptive study on patients with HIV infection with histological diagnosis of KS. The 
study commenced upon approval by KNH-University of Nairobi Ethics and Research Committee. Following consent, 
clinical and demographic data was obtained from participants through verbal interviews and from medical records 
using a data capture form. Follow up was until 10 weeks. Management of patients was at the discretion of the 
attending clinician. Data was analyzed by a statistician using Instat Biostatistics program. 
Results Seventy-four participants aged between 13 to 55 years were enrolled into the study. Males were 42 (56.7%) 
and females 32 (43.2%). Mean age was 36.8 years. The distribution of KS lesions was variable. We demonstrate high 
predilection of lesions for skin and lymph nodes at 62.6%. Other sites were involved were the oral cavity 14.9%. 
Twenty-eight (38%) of the participants had multifocal lesions with a male predominance in skin and viscera with 
male to female ratio of skin 1.8:1 and viscera 7:1 respectively. 
Conclusion: We demonstrate reduced male: female ratio and multifocal distribution of AIDS-related KS lesions with 
predominance in skin and lymph nodes and male predominance in visceral lesions. Future studies should aim to 
determine what favours increase in, KS in women and visceral lesions in males among patients with HIV infection. 
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1. Introduction 
Kaposi’s sarcoma (KS) is a spindle cell malignancy 
caused by infection with human herpes virus 8 (HHV-8). 
The lesions can involve any site in the body, but 
cutaneous lesion is the most common initial 
presentation of KS (Mwanda et al, 2005). There are four 
variants of KS, each, with distinct clinical 
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characteristics: Classic KS is an indolent cutaneous 
disease usually confined to skin of lower extremities 
mainly affecting old men over 70 years of Jewish 
ancestry, characterized by purplish plaques and nodules 
of variable sizes. African Endemic KS was the most 
common type of KS in Equatorial Africa before HIV 
epidemic, the tumour involves the lymphoreticullar 
system, is more aggressive than Classic KS and mainly 
affects young boys. Iatrogenic KS is common among 
patients on chronic immunosuppressive therapy 
following solid allograft transplantation. The tumor 
regresses on immune reconstitution (Ahmed et al, 
2010; Susanna et al, 2016). AIDS-related KS also called 
epidemic KS, is an AIDS defining illness that was initially 
described among young homosexual men in 1981. This 
type of KS mainly involves the lymph nodes, viscera as 
well as the skin. AIDS-related KS was also the first 
malignancy to be recognized as an opportunistic 
malignant sequela of AIDS in resource poor countries, 
where, combined antiretroviral therapy (cART) drugs 
are not readily available (Ahmed et al, 2010; Warren et 
al, 2010).   
In resource rich setting, AIDS-related KS is 
predominantly a disease of homosexual men while in 
sub-Saharan Africa the male predominance is less 
pronounced (Warren et al, 2010) and in one study by 
Emily et al, 2015, the male to female ratio was reversed 
with male to female ratio of 1:2. In Kenya, AIDS- related 
KS accounts for 48% of all AIDS defining malignancies 
(Emily et al, 2015) while in the developed countries, the 
incidence of AIDS- related KS has declined by more than 
70% following the introduction cART . Full remission 
has been reported in about 50% of patients on cART 
(Ahmed et al, 2010; Semeere et al 2012; Susanna et al, 
2016). 
Clinical presentation of AIDS -related KS lesions is 
variable. The distribution of lesions may range from 
minimal incidental disease with solitary, localized lesion 
on the skin to aggressive disseminated visceral disease 
with significant morbidity and mortality. However, 
despite the skin and the mucous membranes being the 
most common initial site at presentation, the lesions 
may occasionally be absent or missed by the clinician 
especially in the dark skinned (Susanna et al, 2016, 
Ahmed et al 2010). Lymph node involvement with KS is 
common and may be the only clinical presentation of 
AIDS- related KS and is characterized by multiple lymph 
node enlargement occasionally with lymphedema 
(Susanna et al, 2016,). Visceral lesions are notably 
found in the respiratory system involving trachea-
bronchial tree, the lung parenchyma and or the pleura 
while in the gastrointestinal tract, KS lesions are mainly 
mucosal and may occur in the absence of cutaneous 
lesions in up to 80% of patients (Susanna et al, 2016; 
Xuefeng et al,2018 ). African and Classic KS lesions tend 
to involve the peripheral skeleton, whereas AIDS-
related KS more commonly involves the axial and/or 
maxillofacial bones with marrow involvement (Liron 
and Bruce 2008). 
A presumptive diagnosis of KS can be made by  
observing the characteristic features of the lesion , 
however biopsy is always recommended to confirm 
diagnosis and rule out other conditions that may 
present like KS (Liron  and Bruce, 2008,  Emily et al,  
2015;  Susanna et al; 2016, Xuefeng et al,2018). 
Therefore, in view of the varied patterns of presentation 
of AIDS- related KS, we deemed it necessary to assess 
the pattern of distribution of KS lesions in patients with 
AIDS -related KS at Kenyatta National Hospital (KNH), a 
national referral hospital in Kenya. The hospital is in a 
resource poor setting where most patients are dark 
skinned and early recognition of lesions, diagnosis and 
initiation of therapy may be delayed due to masking and 
socioeconomic challenges. 
2. Methods 
2.1 Study site 
The study was carried out in the Haematology and 
Radiotherapy Clinics and in adult Medical Oncology 
Wards at KNH.  
2.2 Study design and Study population 
The study design was a descriptive study. The target 
population consisted of HIV infected adult patients 
above 13 years of age with a histology diagnosis of KS. 
2.3 Eligibility criteria 
HIV infected patients with a diagnosis of KS attending 
haematology or radiotherapy clinics or admitted in the 
medical oncology wards willing to sign consent to 
participate in the study were eligible for inclusion in the 
study. Patients with KS in the absence of HIV infection 
were excluded.  
2.4 Patient recruitment and data collection 
Patient management was at the discretion of attending 
haematologist or radio- oncologist. Patients were 
approached as they presented at the haematology or 
radiotherapy clinics or were admitted into the medical 
oncology wards for treatment. Following informed 
consent by patient or guardian for those below 18 
years, data was then extracted from the patients’ 
medical records or through verbal interviews.  
Data was collected on demographic and clinical 
characteristics, past medical and surgical history, the 
anatomic site of the KS lesion, changes observed in the 
lesion(s), development of new lesions and their 
distribution during treatment. The treatment protocols 
for KS were administered weekly or fortnightly for a 
maximum of four doses, and therefore study 
participants were followed up for 10 weeks.   
2.5 Data analysis 
Statistical analysis was performed in Instat Statistical 
Package for Biostatistics. Descriptive statistics were 
used to summarize the findings. 
2.6 Ethical Considerations 
The study was approved by Kenyatta National Hospital - 
University of Nairobi Ethics and Research Committee 
(Ref: KNHERC/01/3111).  
Participant information was anonymized and kept 
confidential.  
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3. Results  
Seventy-four participants were enrolled into the study. 
All participants were newly diagnosed of HIV infection 
and none was on cART.  Age ranged between 13 to 55 
years, with a mean age of 36.8years and peak age 
between 31-40 years, Males were 42 (56.7%) and 
females 32 (43.2%) (Table 1). 
Twenty-eight (38%) participants had multifocal lesions 
with variable distribution. Majority (62.6%) of the 
lesions were found on skin and lymph nodes. Lesions 
were also found in the oral cavity (14.9%), viscera 
(10.8%), and oral cavity/skin (4.9%). There was a male 
predominance in skin and viscera, with male to female 
ratio of 1.8:1 for skin, and 7:1 for viscera lesions 
(Figure 1). 
 
Table 1: Demographic Data of Participants  
 Groups                                                                                     
Number (%) 
N=74 
Gender  Male  42 (57) 
Female  32 (43) 
Age (yrs) <-20 4 (5) 
21-30 20 (27) 
31-40 30 (41) 
41-50 15 (20) 
Above 50 5 (7) 
 
Figure 1: Distribution of the various types of KS lesions  
 
4.0 Discussion 
The study demonstrated peak age between 31-40 years 
and a male to female ratio of 1.3:1. These age 
parameters were like findings in Nigeria by Adamu et al, 
2013. Where they found the peak age was 31-40 years 
and a male to female ratio of 1.3:1. The peak age is two 
decades younger than the peak age of endemic KS which 
is between 50-70 years (Xuefeng et al, 2018). The peak 
age may correspond to peak age of development AIDS 
following acquisition of HIV infection during 
adolescence and young adult life among participants 
(Louis, 2012). The study demonstrated a decline in male 
to female ratio which was in keeping with observations 
in other studies in the world. This decline may reflect 
the heterosexual nature of transmission of HIV infection 
or increased frequency of health seeking behavior and 
testing in female patients. (Adamu et al, 2013; Ahmed et 
al, 2010; Emily et al, 2015, Warren et al, 2010, Louis et 
al 2012). However, we cannot rule out undetermined 
factors favouring acquisition of KS in women with HIV 
infection. Our demographic findings differ from those 
observed in China where, mean age was 43 years and 
male to female ratio was 9:2 (Xuefeng et al, 2018). 
These differences may suggest an ethnic component in 
development of KS in HIV infection. 
To the best of our knowledge, this was the first study to 
determine the pattern of distribution of AIDS-related KS 
lesions in Kenya. We found highly variable distribution 
of KS lesion with multifocal involvement in 37.8% of the 
participants, all of whom were dark skinned. The 
predominant sites of lesion were the skin and lymph 
node at 62.6%. Findings of this study were in keeping 
with findings in other studies by Ahmed et al, 2010; 
Warren et al, 2010; Adamu et al, 2013; Susanna et al, 
2016 and Xuefeng et al, 2018 where they found AIDS-
related KS lesions were distributed in multiple 
anatomic sites and mainly on skin and lymph nodes. 
However, the predominant site of distribution, the skin 
and lymph node were in sharp contrast to findings 
reported in a study in Kenya by Emily et al, 2015, where 
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they found skin involvement was 35%, and viscera 
15%. These differences in lesion distribution between 
our study and that of Emily et al, 2015 may be 
accounted for by differences in patient population and 
methodology.  The pattern of distribution of AIDS- 
related KS lesions vary widely compared to the 
distribution of lesions of endemic KS where the lesions 
are indolent and mainly confined to the skin (Warren et 
al 2010, Louis 2012, Susanna et al,2016, Xuefeng et al 
2018). 
The study also demonstrated male predominance in 
visceral lesion with a male to female ratio of 7:1. Such 
observation has not been reported among the 
publications that we reviewed and we were not able to 
explain the observation. 
A limitation of the study was that the data was largely 
obtained from the medical records which had been 
documented by different clinicians whose uniformity of 
information could not be ascertained. 
5.0 Conclusion  
We demonstrate a predominant distribution of lesions 
in skin and lymph node, and a male predominance in 
visceral involvement. We recommend future studies to 
determine factors responsible for increase in KS among 
women with HIV infection and increase in visceral 
involvement in males.  
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